SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 95 400 KRW -2.25% Market Closed
Market Cap: 7.5T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

P/E
Price to Earnings

130.2
Current
-71.7
Median
21.9
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
130.2
=
Market Cap
7.5T KRW
/
Net Income
57.4B KRW
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
102.6
2-Years Forward
P/E
49.8
3-Years Forward
P/E
29.1

See Also

Discover More